Literature DB >> 1534525

Growth curves of Staphylococcus aureus, Candida albicans, and Moraxella osloensis in propofol and other media.

M Tessler1, A Dascal, S Gioseffini, M Miller, J Mendelson.   

Abstract

Propofol, 2,6 diisopropylphenol, in an emulsion formulation (Diprivan), has been associated with postsurgical infections caused by Staphylococcus aureus, Moraxella osloensis and Candida albicans. These organisms were individually inoculated into each of the following media: (1) the emulsion preparation of propofol, (2) Intralipid 10%, (3) pure 2,6 diisopropylphenol, and (4) trypticase soy broth (TSB). The organisms were incubated and subcultured hourly for eight hours at room temperature. Propofol supported the growth of all three organisms, but for S. aureus and M. osloenis, the growth rate was slower in propofol than in TSB (P less than 0.05). There was no difference between the growth rate of any organism in propofol than in Intralipid 10%. The authors conclude that propofol, in the emulsion formulation, supports bacterial growth and, therefore, must be prepared for administration in an aseptic manner. Also, by administering propofol soon after preparation, the risk of introduction of a significant inoculum to the patient will be reduced.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534525     DOI: 10.1007/BF03008718

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  10 in total

1.  Propofol: can a single ampule be used for multiple patients?

Authors:  G J Downs; P R Haley; J B Parent
Journal:  Anesthesiology       Date:  1991-06       Impact factor: 7.892

2.  Postsurgical infections associated with an extrinsically contaminated intravenous anesthetic agent--California, Illinois, Maine, and Michigan, 1990.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-06-29       Impact factor: 17.586

3.  Contamination of syringes.

Authors:  P M Kempen
Journal:  Can J Anaesth       Date:  1989-11       Impact factor: 5.063

4.  Comparison of propofol induction with thiopentone or methohexitone in short outpatient general anaesthesia.

Authors:  J C Raeder; G Misvaer
Journal:  Acta Anaesthesiol Scand       Date:  1988-11       Impact factor: 2.105

5.  Recovery and morbidity after daycase anaesthesia. A comparison of propofol with thiopentone-enflurane with and without alfentanil.

Authors:  J M Millar; C F Jewkes
Journal:  Anaesthesia       Date:  1988-09       Impact factor: 6.955

6.  Comparison of propofol and thiamylal for induction and maintenance of anaesthesia for outpatient surgery.

Authors:  I H Sampson; H Plosker; M Cohen; J A Kaplan
Journal:  Br J Anaesth       Date:  1988-12       Impact factor: 9.166

7.  Microbial growth comparisons of five commercial parenteral lipid emulsions.

Authors:  K S Crocker; R Noga; D J Filibeck; S H Krey; M Markovic; W P Steffee
Journal:  JPEN J Parenter Enteral Nutr       Date:  1984 Jul-Aug       Impact factor: 4.016

8.  A comparison of propofol and methohexitone as induction agents for day case isoflurane anaesthesia.

Authors:  D P O'Toole; K R Milligan; J P Howe; J S McCollum; J W Dundee
Journal:  Anaesthesia       Date:  1987-04       Impact factor: 6.955

9.  Comparison of propofol with methohexital for outpatient anesthesia.

Authors:  V A Doze; L M Westphal; P F White
Journal:  Anesth Analg       Date:  1986-11       Impact factor: 5.108

10.  A comparative study on the effects of propofol in emulsion and Intralipid on fat metabolism.

Authors:  M R De Sommer; J H Driessen; C M Willems; P C Lust
Journal:  Acta Anaesthesiol Belg       Date:  1990
  10 in total
  4 in total

Review 1.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

2.  Novel lipid and preservative-free propofol formulation: properties and pharmacodynamics.

Authors:  François Ravenelle; Sandra Gori; Dorothée Le Garrec; David Lessard; Laibin Luo; Dana Palusova; J Robert Sneyd; Damon Smith
Journal:  Pharm Res       Date:  2007-11-21       Impact factor: 4.200

Review 3.  Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation.

Authors:  B Fulton; E M Sorkin
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

4.  Propofol emulsion and bacterial contamination.

Authors:  G J McHugh; G M Roper
Journal:  Can J Anaesth       Date:  1995-09       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.